Influence
July 8, 2020

Regenstrief research scientists part of leadership for American Delirium Society Digital Meeting

Dr. Noll Campbell, Dr. Babar Khan, and Dr. Sikandar Khan man “mission control” during the meeting.

The COVID-19 pandemic has posed many challenges for conference organizers around the world. Two Regenstrief Institute research scientists successfully adjusted the American Delirium Society (ADS) conference from in-person to virtual and attracted more than 400 registrations from around the world.

The digital meeting was co-chaired by Indiana University Center for Aging Research at Regenstrief Institute Associate Director Babar Khan, M.D., M.S., and Regenstrief research scientist Noll Campbell, PharmD, M.S. Dr. Khan was the 2019-2020 president of the ADS, and Dr. Campbell is the ADS treasurer.

Regenstrief research scientist Sikandar Khan, D.O., and Indiana University School of Medicine administrative coordinator Makenna Flory assisted with managing the technology during the presentations.

The digital meeting featured about three dozen experts discussing the latest delirium-related research. The ADS works to lead the effort to foster research, education, quality improvement, advocacy and implementation science to minimize the impact of delirium on the health and wellbeing of patients.

Regenstrief researchers are pioneers in the field of delirium and have played an important role in the diagnosis and treatment of ADS. Regenstrief scientist Malaz Boustani, M.D., MPH, was the founding president of the organization.

The next meeting will take place in Indianapolis in March 2021.

Related News

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is

AMIA honors Regenstrief researcher with leadership award

Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, was awarded a 2024 leadership award by the American Medical